---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-000615"
form_type: "8-K"
ticker: "ZSQR"
cik: "0001759186"
company_name: "Z Squared Inc."
filed_at: "2024-02-01T23:59:59+00:00"
generated_at: "2026-06-06T11:16:26.514659+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Coeptis receives Nasdaq deficiency notice for minimum bid price non-compliance

## Summary
- Nasdaq notified Coeptis that its common stock closing bid price was below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until July 29, 2024, to regain compliance by closing at $1.00 for 10 consecutive days.
- If not cured, a second 180-day extension may be available if other listing standards are met.
- Delisting could reduce liquidity, limit capital access, and trigger penny stock rules, per updated risk factors.

## SEC filing metadata
- accession: 0001683168-24-000615
- form_type: 8-K
- ticker: ZSQR
- cik: 0001759186
- company_name: Z Squared Inc.
- filed_at: 2024-02-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759186/000168316824000615/0001683168-24-000615-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759186/000168316824000615/coeptis_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-000615
- JSON: https://secwatch.observer/filing/0001683168-24-000615.json
- Plain text: https://secwatch.observer/filing/0001683168-24-000615.txt

## Key facts
- Listing & Compliance Notices
  Z Squared Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: January 29, 2024, Coeptis Therapeutics Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share (“Common Stock”), for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2) (the “Notice”). The Notice has no immediate effe
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759186/000168316824000615/0001683168-24-000615-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.